Zidovudine after occupational exposure to HIV
- AZT Suggested For Seronegatives. // Advocate;11/10/87, Issue 485, p45
Reports that people at high risk for HIV infection should be given an antiviral like AZT to prevent infection in the United States. Effectiveness of such chemotherapy; Proposed AIDS vaccine; Protection against HIV infection.
- Zidovudine approved in pregnancy. // Drug Topics;8/22/94, Vol. 138 Issue 16, p7
No abstract available.
- AZT in pregnancy. Rodgers, Katie // Drug Topics;7/25/94, Vol. 138 Issue 14, p29
Reports on the results of studies on the effectivity of administering azidothymidine (AZT) during pregnancy in HIV-positive women to reduce the risk that the patient will give birth to an HIV-positive baby. Details on two studies; Cost consideration; Problems of AZT usage.
- Beginning to Make Progress against HIV. Wilfert, Catherine M. // New England Journal of Medicine;11/28/96, Vol. 335 Issue 22, p1678
Opinion. Discusses efforts to reduce perinatal human immunodeficiency virus (HIV) infection. Evidence of the preventive efficacy of zidovudine demonstrated by Sperling et al.; How Sperling's work, called Protocol 076, is being implemented in the United States; Details of three studies...
- Recommendations of the U.S. Public Health Service Task Force on the use of zidovudine to reduce... Mofenson, Lynne; Balsley, James // MMWR: Morbidity & Mortality Weekly Report;8/5/94 Supplement RR-11, Vol. 43 Issue 30, p1
Presents the recommendations of the US Public Health Service Task Force on the use of zidovudine (ZDV) to reduce perinatal transmission of human immunodeficiency virus (HIV). Results of the AIDS Clinical Trials Group Protocol 076 demonstration; Potential long-term adverse effects of a ZDV...
- Ready or Not�Intrapartum Prevention of Perinatal HIV Transmission in Illinois. Bryant Borders, Ann E.; Eary, Rebecca L.; Olszewski, Yolanda; Statton, Anne; Handler, Arden; Cohen, Mardge H.; Garcia, Patricia M. // Maternal & Child Health Journal;Sep2007, Vol. 11 Issue 5, p485
Objectives: The overall readiness of Illinois birthing hospitals to comply with the 2003 Illinois HIV Perinatal Prevention Act and prevent perinatal HIV transmission, and the hospital characteristics that predict readiness were examined. Methods: Nurse Managers of all 137 Illinois birthing...
- Short course antiretroviral regimens to reduce maternal transmission of HIV. Wilkinson, David; Abdool Karim, Salim S; Coovadia, Hoosen M // BMJ: British Medical Journal (International Edition);02/20/99, Vol. 318 Issue 7182, p479
Editorial. Provides information on the results of an investigation conducted in Bangkok, Thailand which suggested that zidovudine intervention may help prevent HIV infection in children in developing countries. Implication of the results; Reaction to the report; Implementation of the 076...
- A Trial of Shortened Zidovudine Regimens to Prevent Mother-to-Child Transmission of Human Immunodeficiency Virus Type 1. Lallemant, Marc; Jourdain, Gonzague; Le Coeur, Sophie; Kim, Soyeon; Koetsawang, Suporn; Comeau, Anne Marie; Phoolcharoen, Wiput; Essex, Max; McIntosh, Kenneth; Vithayasai, Vicharn // New England Journal of Medicine;10/05/2000, Vol. 343 Issue 14, p982
Background: The optimal duration of zidovudine administration to prevent perinatal transmission of human immunodeficiency virus type 1 (HIV-1) should be determined to facilitate its use in areas where resources are limited. Methods: We conducted a randomized, double-blind equivalence trial of...
- Risk adapted transmission prophylaxis to prevent vertical HIV-1 transmission: Effectiveness and safety of an abbreviated regimen of postnatal oral Zidovudine. Neubert, Jennifer; Pfeffer, Maren; Borkhardt, Arndt; Niehues, Tim; Adams, Ortwin; Bolten, Mareike; Reuter, Stefan; Stannigel, Hans; Laws, Hans-Juergen // BMC Pregnancy & Childbirth;2013, Vol. 13 Issue 1, p1
Background: Antiretroviral drugs including zidovudine (ZDV) are effective in reducing HIV mother to child transmission (MTCT), however safety concern remains. The optimal duration of postnatal ZDV has not been established in clinical studies and there is a lack of consensus regarding optimal...